申请人:Takeda Pharmaceutical Company Limited
公开号:EP1535922A1
公开(公告)日:2005-06-01
A novel pyrrolopyridine derivative which is a compound represented by the formula
wherein Ring A represents an optionally substituted pyridine ring; X represents an electron-attracting group; Y represents an optionally substituted divalent C1-6 chain hydrocarbon group; R1 represents an optionally substituted hydrocarbon group; and R2 and R3 each independently represents hydrogen, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, or R2 and R3 may form an optionally substituted ring in cooperation with the adjacent nitrogen atom, or a salt of the compound. The pyrrolopyridine derivative has vanilloid receptor agonist activity and is useful as medicines such as a preventive/therapeutic agent and analgesic for overactive bladder.
一种新型吡咯并吡啶衍生物,它是由式表示的化合物
其中环 A 代表任选取代的吡啶环;X 代表引电子基团;Y 代表任选取代的二价 C1-6 链烃基团;R1 代表任选取代的烃基团;R2 和 R3 各自独立地代表氢、任选取代的烃基团或任选取代的杂环基团,或 R2 和 R3 可与邻近的氮原子配合形成任选取代的环,或该化合物的盐。吡咯并吡啶衍生物具有类香草素受体激动剂活性,可用作药物,如膀胱过度活动症的预防/治疗剂和镇痛剂。